Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > CRIXlabs Joins the ROCK Health Incubator: ROCK Health is the world’s leading healthcare incubator looking to make meaningful change through scalable, innovative technology.

Abstract:
CRIXlabs, Inc. today announced joining the ROCK Health incubator located in San Francisco, CA. CRIXlabs is the creator of NuSilico, the #1 predictive nanoparticle software used by Pharma.

CRIXlabs Joins the ROCK Health Incubator: ROCK Health is the world’s leading healthcare incubator looking to make meaningful change through scalable, innovative technology.

San Diego, CA | Posted on June 5th, 2013

"We couldn't be more excited to be part of the family over at ROCK Health" said Jon Stenstrom, CRIXlabs' CEO and Co-Founder. "CRIXlabs' NuSilico software enables pharmaceutical companies to create more effective treatments with reduced side-effects, for cancer and a wide variety of other diseases." Jon has a strong healthcare product development background and holds a Master of Engineering from San Diego State University.

The CRIXlabs team includes Dr. Shalini Ananda, CTO and Co-Founder with expertise in software development and nanotechnology and Dr. Garrett Smith, Co-Founder and advisor, a serial entrepreneur with expertise in nanoparticle synthesis and a former Stanford BioDesign Fellow; both of which received their PhDs from the University of California, San Diego.

The ROCK Health announcement: rockhealth.com/2013/06/new-class-new-partners-new-space/

####

About CRIXlabs, Inc.
Creators of NuSilico, the #1 predictive nanoparticle software used by Pharma.

NuSilico increases the probability of finding the next blockbuster drug. Today, Pharma uses NuSilico to identify unfavorable nanotherapeutic candidates early, potentially saving years of development time and millions of dollars. NuSilico can optimize nanoparticle platforms, increasing their ability to treat diseases such as cancer more effectively and with lower side-effects.

CRIXlab’s unique background in software, nanoparticle synthesis, and imaging helps researchers look at all possible scenarios prior to beginning pre-clinical trials.

NuSilico uses a proprietary database and algorithms to determine the biodistribution and half-life of nanoparticle platforms prior to expensive preclinical trials. Early identification helps ensure the research process is efficient and cost-effective for the client.

CRIXlabs has been accepted into the ROCK Health incubator in San Francisco and have terms on the table with Kleiner Perkins, Mohr Davidow, Aberdare Ventures, and the Mayo Clinic.

They have begun working with a Top 10 Pharmaceutical company on their nanoparticle platforms. They are in active discussions with the Top 5 Pharmaceutical companies for the use of their software.

For more information, please click here

Contacts:
Jon Stenstrom, MEng.
Co-Founder & CEO
CRIXlabs, Inc.
858-598-4272

Copyright © CRIXlabs, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

UCLA chemists synthesize narrow ribbons of graphene using only light and heat: Tiny structures could be next-generation solution for smaller electronic devices December 8th, 2017

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Device makes power conversion more efficient: New design could dramatically cut energy waste in electric vehicles, data centers, and the power grid December 8th, 2017

JPK Instruments announce partnership with Swiss company, Cytosurge AG. The partnership makes Cytosurge’s FluidFM® technology available on the JPK NanoWizard® AFM platform December 8th, 2017

Software

EC Project Aims at Creating and Commercializing Cyber-Physical-System Solutions November 14th, 2017

Leti Launches Emulator Service to Boost ROI and Speed Time to Market for European Chipmakers: Anchored by Mentor Veloce Emulator Machine, Leti’s Offer Includes Support for Design, Debug and Analysis of Results August 31st, 2017

Technology Companies Join Forces for TEM Imaging and Analysis August 3rd, 2017

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

180 Degree Capital Corp. Leads Investment in TheStreet, Inc.; Investment Enables Removal of Capital Structure Overhang November 14th, 2017

180 Degree Capital Corp. Appoints Investment Banking Veteran Parker Weil to Its Board of Directors August 2nd, 2017

Announcements

UCLA chemists synthesize narrow ribbons of graphene using only light and heat: Tiny structures could be next-generation solution for smaller electronic devices December 8th, 2017

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Device makes power conversion more efficient: New design could dramatically cut energy waste in electric vehicles, data centers, and the power grid December 8th, 2017

JPK Instruments announce partnership with Swiss company, Cytosurge AG. The partnership makes Cytosurge’s FluidFM® technology available on the JPK NanoWizard® AFM platform December 8th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project